- Corporate Officers - G
- Greenleaf Peter
Insider Trading History of Greenleaf Peter
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Greenleaf Peter since 2016.
This trader's CIK number is 1363683.
At the time of last reporting, Greenleaf Peter was the Chief Executive Officer of Aurinia Pharmaceuticals Inc.. (stock ticker symbol AUPH).
Also see all insider trading activities at Aurinia Pharmaceuticals Inc..
Note that in the past
Greenleaf Peter also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Avalo Therapeutics, Inc. (CERC) by Greenleaf Peter
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | CERC | 12,500 | $49,750 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Biodelivery Sciences International Inc (BDSI) by Greenleaf Peter
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | BDSI | 0 | $0 | 0 | $0 | 10,246 | $0 |
| 2021 | BDSI | 0 | $0 | 0 | $0 | 35,000 | $0 |
| 2020 | BDSI | 0 | $0 | 0 | $0 | 35,000 | $0 |
| 2019 | BDSI | 0 | $0 | 0 | $0 | 21,144 | $0 |
| 2018 | BDSI | 0 | $0 | 0 | $0 | 3,644 | $0 |
Yearly summary of insider trading at Sucampo Pharmaceuticals, Inc. (SCMP) by Greenleaf Peter
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | SCMP | 0 | $0 | 200,000 | $3,368,806 | 200,000 | $1,349,999 |
Yearly summary of insider trading at Aurinia Pharmaceuticals Inc. (AUPH) by Greenleaf Peter
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | AUPH | 0 | $0 | 360,540 | $2,871,124 | 0 | $0 |
| 2024 | AUPH | 0 | $0 | 126,981 | $711,093 | 0 | $0 |
| 2023 | AUPH | 0 | $0 | 32,750 | $292,785 | 0 | $0 |
| 2022 | AUPH | 0 | $0 | 9,068 | $108,906 | 0 | $0 |
| 2021 | AUPH | 5,125 | $54,478 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Greenleaf Peter:
1. Avalo Therapeutics, Inc. (CERC)
2. Biodelivery Sciences International Inc (BDSI)
3. Sucampo Pharmaceuticals, Inc. (SCMP)
4. Aurinia Pharmaceuticals Inc. (AUPH)
Table 1. Insider trading of Avalo Therapeutics, Inc. (CERC) by Greenleaf Peter
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-05-18 | CERC | Buy | 12,500 | 3.98 | 49,750 |
Table 2. Insider trading of Biodelivery Sciences International Inc (BDSI) by Greenleaf Peter
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-01-27 | BDSI | Option Ex | 10,246 | .00 | 0 |
| 2021-08-06 | BDSI | Option Ex | 35,000 | .00 | 0 |
| 2020-08-07 | BDSI | Option Ex | 35,000 | .00 | 0 |
| 2019-08-13 | BDSI | Option Ex | 21,144 | .00 | 0 |
| 2018-08-14 | BDSI | Option Ex | 3,644 | .00 | 0 |
Table 3. Insider trading of Sucampo Pharmaceuticals, Inc. (SCMP) by Greenleaf Peter
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-11-28 | SCMP | Sale | 117,541 | 16.91 | 1,987,618 |
| 2016-11-29 | SCMP | Sale | 82,459 | 16.75 | 1,381,188 |
| 2016-11-28 | SCMP | Option Ex | 117,541 | 6.75 | 793,401 |
| 2016-11-29 | SCMP | Option Ex | 82,459 | 6.75 | 556,598 |
Table 4. Insider trading of Aurinia Pharmaceuticals Inc. (AUPH) by Greenleaf Peter
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-03-03 | AUPH | Sale | 195,593 | 8.00 | 1,564,744 |
| 2025-03-04 | AUPH | Sale | 164,947 | 7.92 | 1,306,380 |
| 2024-03-06 | AUPH | Sale | 126,981 | 5.60 | 711,093 |
| 2023-03-02 | AUPH | Sale | 32,750 | 8.94 | 292,785 |
| 2022-03-02 | AUPH | Sale | 9,068 | 12.01 | 108,906 |
| 2021-05-11 | AUPH | Buy | 5,125 | 10.63 | 54,478 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Greenleaf Peter
(Chief Executive Officer of Aurinia Pharmaceuticals Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.